Delivery of fluorouracil and siRNA by mesoporous silica nanoparticles to drug resistant colorectal cancer

Mesoporous silica nanoparticle based drug and gene delivery system was developed to overcome the acquired drug resistance in colorectal cancer by targeted delivery of anti-cancer drug in the cytoplasm of the cancer cells and silencing the gene expression related to drug resistance.